AKL+ROS1
Group of caregivers and patients affected by non-small cell lung cancer expressing a genetic mutation (ALK+, ROS1, NRG1,...)
The association ALK+ROS1was born in 2021 from the encounter of a few ALK+ patients who were joined by ROS1 patients and caregivers. They shared the need to create a specific group for these pathologies, rare types of lung cancer. The association has several objectives:
- Make known theserare forms of lung cancer and have them recognized as a chronic disease
- Supporting the sick dealing with the disease and providing them with help, for example, by referring them to doctors specialized in their ALK or ROS1 pathology
- To be preferred partners Doctorsspecialized in ALK or ROS1 lung cancers
- Support research institutions and laboratories to develop innovative treatments
To learn more about the association and its actions: ALK+ROS1.